A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work - Join Clinical Trial NCTNCT06290128
How to Join This Clinical Trial - NCTNCT06290128
Learn how to participate in this PHASE3 trial studying an investigational therapy for Polyneuropathies, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Polyradiculoneuropathy. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Polyneuropathies, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Polyradiculoneuropathy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Polyneuropathies, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Polyradiculoneuropathy
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06290128 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 105 locations. Find a study site near you:
Clinical Research Site
Homewood, Alabama 35209 - United States
Status: RECRUITING
Clinical Research Site
Los Angeles, California 90033 - United States
Status: RECRUITING
Clinical Research Site
Orange, California 92868 - United States
Status: RECRUITING
Clinical Research Site
New Haven, Connecticut 06510 - United States
Status: RECRUITING
Clinical Research Site
Glenview, Illinois 60026 - United States
Status: RECRUITING
Clinical Research Site
Kansas City, Kansas 66160 - United States
Status: RECRUITING
Clinical Research Site
Alexandria, Louisiana 71301 - United States
Status: RECRUITING
Clinical Research Site
New Orleans, Louisiana 70121 - United States
Status: RECRUITING
Clinical Research Site
Baltimore, Maryland 21287 - United States
Status: RECRUITING
Clinical Research Site
Boston, Massachusetts 92114 - United States
Status: RECRUITING
And 95 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Polyneuropathies, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Polyradiculoneuropathy:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships